Evaluating Alcohol Use in Alcoholic Liver Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorNicole T Shen

About this trial

This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered for inclusion. Subjects able to give consent are included.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

alcoholic liver disease able to consent

Disqualifiers

without alcoholic liver disease unable to consent

Trial population

subjects with alcoholic liver disease

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • survey

    Other intervention

    surveys will be administered at inclusion and follow-ups

Treatment groups

160 Participants
are divided into 1 treatment group
Group A: alcohol liver disease1 intervention

Trial outcomes

Primary outcomes

1

alcohol recidivism assessed by questionnaire

Follow-up questionnaires will be administered at 6 months assessing for alcohol use

Time frame
6 months
2

alcohol recidivism assessed by clinical interview

Follow-up interviews will be conducted at 6 months assessing for alcohol use

Time frame
6 months
3

alcohol recidivism assessed by urine ethyl glucuronide

Follow-up urine testing may be conducted at 6 months assessing for alcohol use

Time frame
6 months
4

alcohol recidivism assessed by blood

Follow-up blood testing may be conducted at 6 months assessing for alcohol use

Time frame
6 months

Secondary outcomes

1

alcohol recidivism assessed by questionnaire

Follow-up questionnaires will be administered after 6 months assessing for alcohol use

Time frame
after 6 months
2

alcohol recidivism assessed by clinical interview

Follow-up clinical interviews will be conducted after 6 months assessing for alcohol use

Time frame
after 6 months
3

alcohol recidivism assessed by urine ethyl glucuronide

Follow-up urine testing may be conducted after 6 months assessing for alcohol use

Time frame
after 6 months
4

alcohol recidivism assessed by blood

Follow-up blood testing may be conducted after 6 months assessing for alcohol use

Time frame
after 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Nicole T Shen

Lead sponsor

New York Presbyterian Hospital

Sponsor institution